Arrow Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Sell |
3,302
-83
| -2% | -$37K | 0.15% | 80 |
|
|
2025
Q1 | $1.64M | Sell |
3,385
-2,220
| -40% | -$1.08M | 0.18% | 78 |
|
|
2024
Q4 | $2.26M | Buy |
5,605
+10
| +0.2% | +$4.03K | 0.21% | 73 |
|
|
2024
Q3 | $2.6M | Sell |
5,595
-411
| -7% | -$191K | 0.24% | 71 |
|
|
2024
Q2 | $2.82M | Buy |
6,006
+315
| +6% | +$148K | 0.27% | 68 |
|
|
2024
Q1 | $2.38M | Buy |
5,691
+2,342
| +70% | +$979K | 0.24% | 71 |
|
|
2023
Q4 | $1.36M | Buy |
3,349
+1,537
| +85% | +$625K | 0.14% | 90 |
|
|
2023
Q3 | $630K | Buy |
1,812
+1,492
| +466% | +$519K | 0.07% | 116 |
|
|
2023
Q2 | $113K | Buy |
320
+12
| +4% | +$4.22K | 0.01% | 170 |
|
|
2023
Q1 | $97K | Sell |
308
-2
| -0.6% | -$630 | 0.01% | 179 |
|
|
2022
Q4 | $90K | Sell |
310
-5
| -2% | -$1.45K | 0.01% | 181 |
|
|
2022
Q3 | $91K | Hold |
315
| – | – | 0.01% | 179 |
|
|
2022
Q2 | $89K | Hold |
315
| – | – | 0.01% | 178 |
|
|
2022
Q1 | $82K | Hold |
315
| – | – | 0.01% | 192 |
|
|
2021
Q4 | $69K | Hold |
315
| – | – | 0.01% | 196 |
|
|
2021
Q3 | $57K | Hold |
315
| – | – | 0.01% | 207 |
|
|
2021
Q2 | $63K | Hold |
315
| – | – | 0.01% | 200 |
|
|
2021
Q1 | $67K | Hold |
315
| – | – | 0.01% | 197 |
|
|
2020
Q4 | $75K | Hold |
315
| – | – | 0.01% | 183 |
|
|
2020
Q3 | $86K | Sell |
315
-20
| -6% | -$5.46K | 0.02% | 173 |
|
|
2020
Q2 | $97K | Hold |
335
| – | – | 0.02% | 179 |
|
|
2020
Q1 | $79K | Buy |
335
+15
| +5% | +$3.54K | 0.02% | 186 |
|
|
2019
Q4 | $70K | Hold |
320
| – | – | 0.01% | 199 |
|
|
2019
Q3 | $54K | Sell |
320
-10
| -3% | -$1.69K | 0.01% | 210 |
|
|
2019
Q2 | $61K | Hold |
330
| – | – | 0.01% | 214 |
|
|
2019
Q1 | $61K | Hold |
330
| – | – | 0.01% | 213 |
|
|
2018
Q4 | $55K | Hold |
330
| – | – | 0.01% | 205 |
|
|
2018
Q3 | $64K | Hold |
330
| – | – | 0.01% | 211 |
|
|
2018
Q2 | $56K | Hold |
330
| – | – | 0.01% | 199 |
|
|
2018
Q1 | $54K | Hold |
330
| – | – | 0.01% | 205 |
|
|
2017
Q4 | $49K | Buy |
330
+30
| +10% | +$4.46K | 0.01% | 209 |
|
|
2017
Q3 | $46K | Hold |
300
| – | – | 0.01% | 215 |
|
|
2017
Q2 | $39K | Hold |
300
| – | – | 0.01% | 227 |
|
|
2017
Q1 | $33K | Hold |
300
| – | – | 0.01% | 233 |
|
|
2016
Q4 | $22K | Hold |
300
| – | – | 0.01% | 254 |
|
|
2016
Q3 | $26K | Hold |
300
| – | – | 0.01% | 245 |
|
|
2016
Q2 | $26K | Hold |
300
| – | – | 0.01% | 245 |
|
|
2016
Q1 | $24K | Sell |
300
-7
| -2% | -$560 | 0.01% | 252 |
|
|
2015
Q4 | $39K | Buy |
307
+7
| +2% | +$889 | 0.01% | 224 |
|
|
2015
Q3 | $31K | Buy |
+300
| New | +$31K | 0.01% | 220 |
|
|
2014
Q2 | – | Sell |
-195
| Closed | -$14K | – | 362 |
|
|
2014
Q1 | $14K | Hold |
195
| – | – | ﹤0.01% | 269 |
|
|
2013
Q4 | $14K | Buy |
195
+165
| +550% | +$11.8K | ﹤0.01% | 257 |
|
|
2013
Q3 | $2K | Sell |
30
-30
| -50% | -$2K | ﹤0.01% | 339 |
|
|
2013
Q2 | $5K | Buy |
+60
| New | +$5K | ﹤0.01% | 298 |
|